Jump to content

AbbVie Streamlines Multi-Specifics Biologics Discovery and Engineering with Genedata

May 15, 2024 | 7:00 PDT | 10:00 EDT | 16:00 CEST 

Debra Touw, Principal Scientist, Multi-specifics Biologics at AbbVie, will show how AbbVie has fully digitalized processes and streamlined operations in their high-throughput multi-specific biologics discovery and engineering workflows using Genedata Biologics. By eliminating error-prone manual molecule design processes and storing all discovery information in a central database, AbbVie has increased efficiency and improved data quality. AbbVie scientists now have real-time access to all proprietary binding region data obtained from diverse experimental strategies, including phage-display, B-cell screening, and molecular modelling. AbbVie uses Genedata’s Molecular Workspace to engineer novel multi-specific formats in building block fashion and directly integrate with laboratory automation to enable rapid standardized cloning and expression workflows.

Learn how AbbVie uses Genedata Biologics to:

  • Store biotherapeutics data in one place
  • Ensure error-free handover between teams
  • Design and produce biomolecules in high-throughput
  • Automate lab operations
  • Collate critical data for patent applications
  • Link to external data systems


Scheduling conflict? Register and you will receive a link to view an on-demand recording if you miss the live event.

May 15, 2024, 16:00 CEST